4.43BMarket Cap
LossP/E TTM
Key Figures
16.050Open
16.140High
3.51MVolume
LossP/E TTM
42.70P/E Dynamic
--Dividend TTM
1.24%Turnover Ratio
16.090Prev. Close
15.230Low
40.82MTurnover
LossP/E Static
7.67P/B
0.00%Div Yield TTM
4.67%ROA
42.50052wk High
0.85Volume Ratio
-378.26MNet Profit
282.53MShares
-2.7620EPS TTM
--Beta
--ROE
16.28052wk Low
5.66%Amplitude
65.39%Gross Margin
4.43BMarket Cap
-2.59Reward/Risk
3.73%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Caris Life Sciences Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 83 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 27.92.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Caris Life Sciences Inc's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Caris Life Sciences Inc Highlights
StrengthsRisks
Caris Life Sciences Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Caris Life Sciences Inc
CAI
12
Zimmer Biomet Holdings Inc
ZBH
31
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
Caris Life Sciences Inc Info
Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.
Ticker SymbolCAI
CompanyCaris Life Sciences Inc
CEOHalbert (David Dean)
Websitehttps://www.carislifesciences.com/
Shareholders
FAQs
What is the current price of Caris Life Sciences Inc (CAI)?
The current price of Caris Life Sciences Inc (CAI) is 15.67.
What is the symbol of Caris Life Sciences Inc?
The ticker symbol of Caris Life Sciences Inc is CAI.
What is the 52-week high of Caris Life Sciences Inc?
The 52-week high of Caris Life Sciences Inc is 42.50.
What is the 52-week low of Caris Life Sciences Inc?
The 52-week low of Caris Life Sciences Inc is 16.28.
What is the market capitalization of Caris Life Sciences Inc?
The market capitalization of Caris Life Sciences Inc is 4.43B.
Is Caris Life Sciences Inc (CAI) currently rated as Buy, Hold, or Sell?
According to analysts, Caris Life Sciences Inc (CAI) has an overall rating of Buy, with a price target of 27.92.
What is the Earnings Per Share (EPS TTM) of Caris Life Sciences Inc (CAI)?
The Earnings Per Share (EPS TTM) of Caris Life Sciences Inc (CAI) is -3.22.